The growing inhibition action of PEG modified magnetic 5-Fluorouracil albumin microspheres combined with constant external magnetic fields on human colon carcinoma LoVo cells in vitro

doi:10.3877/cma.j.issn.2095-655X.2016.04.004

Abstract

Abstract:

Objective

To investigate the growth inhibiting action of PEG modified magnetic 5-Fluorouracil albumin microspheres (PEG-5-FU-MAMS) combined with constant external magnetic fields on human colorectal carcinoma LoVo cells in vitro and the mechanism.

Methods

The PEG-5-FU-MAMS were prepared by emulsification/solidification method.The cultured LoVo cells were divided into four groups.Group A was processed with PEG-5-FU-MAMS combined with external magnetic fields, group B was PEG-5-FU-MAMS without magnetic fields, group C was free 5-FU, group D was pure magnetic field.The growth of LoVo cells was observed under an inverted microscopy, and the inhibitory rate (IR) was assayed by methyl thiazol tetrazolium (MTT) assay.

Results

The obtained microspheres (MS) were spherical and about (1.32±0.50)μm in size.The drug loading was (5.31±0.13)% and the MS had good magnetic responsibility.The release rate of 5-Fu in vitro showed that PEG-5-FU-MAMS had pronounced sustained-release effect.LoVo cells grew well and had good refraction after 24 h. Under the microscope, tumor cells were completely adherent.After different treatment, the tumor growth showed no difference on tumor cells in pure magnetic group.The IR of pure PEG-5-FU-MAMS group and free 5-FU group at same drug concentration were similar, there were no significant differences between them(q=2.02, 2.11, 2.74; P>0.05). Compared with pure PEG-5-FU-MAMS and free 5-FU group, when the concentration of 5-FU exceeded 10.0 mg/L, IR was significantly increased after PEG-5-FU-MAMS combined with constant external magnetic fields(F=62.09, 66.74, 56.62, 66.13; P<0.05).

Conclusions

PEG-5-FU-MAMS is characterized with good shape, particle size, drug loading, magnetic responsibility and drug release.The growth inhibiting action is significantly enhanced after PEG-5-FU-MAMS combined with constant external magnetic fields.

Key words: Fluorouracil, Albumins, Microspheres, LoVo cells

Jiangang Liu. The growing inhibition action of PEG modified magnetic 5-Fluorouracil albumin microspheres combined with constant external magnetic fields on human colon carcinoma LoVo cells in vitro[J]. Chinese Journal of Diagnostics(Electronic Edition), 2016, 04(04): 231-235.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhzdxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-655X.2016.04.004

https://zhzdxdzzz.cma-cmc.com.cn/EN/Y2016/V04/I04/231

Figures/Tables 3

References 20

[1]	刘建刚,刘志超,钱志勇, 等. 聚乙二醇修饰磁性5-氟尿嘧啶白蛋白微球的制备与表征[J]. 中华实验外科杂志, 2008, 25(1): 36-38.
[2]	陈薇,刘娟娟,罗艳. 磁场的细胞生物学效应不统一之现状分析[J]. 中国细胞生物学学报, 2014, 36(9): 1281-1288.
[3]	张皓楠,王益民,杨琳, 等. 永磁磁场对大鼠胰岛细胞的增殖、活性影响的实验研究[J]. 天津中医药, 2013, 30(11): 674-677.
[4]	刘志超,刘建刚,孔霞, 等. 两种5-氟尿嘧啶磁性白蛋白微球对肝脏靶向性的研究[J]. 中国现代普通外科进展, 2010, 13(8): 594-596.
[5]	王文,蔡锦方,曹学成, 等. 外部磁场介导下万古霉素磁性微球靶向治疗大鼠骨感染[J]. 中国组织工程研究与临床康复, 2010, 14(38): 7108-7111.
[6]	崔敬敬,金光玉,夏雷, 等. 超顺磁性氧化铁纳米粒在磁共振成像和药物传递系统中的应用[J]. 国际药学研究杂志, 2015, 42(5): 601-605.
[7]	Lee PW,Hsu SH,Wang JJ, et al.The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles [J]. Biomaterials, 2010, 31(6): 1316-1324.
[8]	Zhang Y,Yang M,Park JH, et al.A surface-charge study on cellular-ptake behavior of F3-peptide-conjugated iron oxide nanoparticles[J]. Small, 2009, 5(17): 1990-1996.
[9]	刘建刚,乔森,袁常秀, 等.5-氟尿嘧啶磁性白蛋白微球对离体牛肝脏射频消融增效作用的研究[J]. 中华诊断学电子杂志, 2014, 2(3): 202-205.
[10]	张小云,张晓鄂. 恒定磁场对细胞生长分裂的影响[J]. 科学通报, 1989, 34(24): 1901-1904.
[11]	孙诚谊,俞超,刘建刚, 等.5-氟尿嘧啶磁性微球的制备及对人胰腺癌细胞的抑制作用[J]. 中华消化外科杂志, 2007, 6(4): 263-265.
[12]	张静,孙润广,齐浩, 等. 脂肪酸甲胺铂配合物的结构表征及磁场对其抗癌活性的影响[J]. 化学学报, 2000, 58(6): 704-712.
[13]	Cui G,Zhou D, et al.The primary study of the method using heating in rabbits’ brain tissue[J]. Acta Academiae Medicine Suzhou, 1997, 17(3): 403-404.
[14]	顾宁,李洋. 纳米颗粒对细胞膜的作用[J]. 生物物理学报, 2010, 26(8): 623-637.
[15]	Bothun GD.Hydrophobic silver nanoparticles trapped in lipid bilayers：Size distribution, bilayer phase behavior, and optical properties[J]. J Nanobiotechnology, 2008, 6(1): 13.
[16]	Hinderliter A,Biltonen RL,Almeida PFF.Lipid modulation of protein-induced membrane domains as a mechanism for controlling signal transduction[J]. Biochemistry, 2004, 43(22): 7102-7110.
[17]	May S. Theories on structural perturbations of lipid bilayers[J]. Curr Opin Colloid Interface Sci, 2000, 5(3-4): 244-249.
[18]	Xing CY,Ollila OHS,Vattulainen I, et al.Asymmetric nature of lateral pressure profiles in supported lipid membranes and its implications for membrane protein functions[J]. Soft Matter, 2009, 5(17): 3258-3261.
[19]	Ollila OHS,Risselada H,Louhivuori M, et al.3D pressure field in lipid membranes and membrane-protein complexes[J]. Phys Rev Lett, 2009, 102(7): 078101.
[20]	Qiao R,Roberts AP,Mount AS, et al.Translocation of C60 and its derivatives across a lipid bilayer[J]. Nano Lett, 2007, 7(3): 614-619.

组别	1.0 mg/L	2.0 mg/L	5.0 mg/L	10.0 mg/L	20.0 mg/L	50.0 mg/L	100.0 mg/L
A组	29.1±1.3	37.5±1.8	42.3±2.3	59.8±2.6	78.1±2.9	80.7±3.5	87.4±3.7
B组	12.7±1.1^a	18.2±1.4^ab	25.9±1.9^ab	43.1±2.2^a	54.3±2.5^a	59.4±2.8^a	63.7±3.0^a
C组	17.1±1.5^ab	23.7±1.6^ab	28.4±2.2^ab	39.6±2.3^ab	57.5±2.8^ab	55.6±3.0^ab	58.5±3.1^ab
F值	125.92	114.66	51.14	62.09	66.74	56.62	66.13
P值	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01

组别	1.0 mg/L	2.0 mg/L	5.0 mg/L	10.0 mg/L	20.0 mg/L	50.0 mg/L	100.0 mg/L
A组	29.1±1.3	37.5±1.8	42.3±2.3	59.8±2.6	78.1±2.9	80.7±3.5	87.4±3.7
B组	12.7±1.1^a	18.2±1.4^ab	25.9±1.9^ab	43.1±2.2^a	54.3±2.5^a	59.4±2.8^a	63.7±3.0^a
C组	17.1±1.5^ab	23.7±1.6^ab	28.4±2.2^ab	39.6±2.3^ab	57.5±2.8^ab	55.6±3.0^ab	58.5±3.1^ab
F值	125.92	114.66	51.14	62.09	66.74	56.62	66.13
P值	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01	<0.01

Please choose a citation manager

Content to export